Nifedipine enhances cGMP production through the activation of soluble guanylyl cyclase in rat ventricular papillary muscle

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 4, 2005, Pages 511-514

  Seya, Kazuhiko ^a   Furukawa, Ken Ichi ^a   Yoshida, Kazuhiko ^a   Narita, Reina ^a   Motomura, Shigeru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; N(G) METHYLARGININE; NIFEDIPINE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRODE; ENZYME ACTIVATION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; HEART VENTRICLE WALL; INOTROPISM; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CYCLIC GMP; ENZYME ACTIVATION; GUANYLATE CYCLASE; HEART VENTRICLES; MALE; NIFEDIPINE; PAPILLARY MUSCLES; RATS; RATS, WISTAR;

EID: 17144383631     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055740     Document Type: Article

References (16)

1. Berkels, R., Egink, G., Marsen, T. A., Bartels, H., Roesen, R., Klaus, W. (2001) Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 37: 240-245
2. Dhein, S., Zhao, Y., Simsek, S., Salameh, A., Klaus, W. (1995) Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds. J. Cardiovasc. Pharmacol. 26: 784-791
3. Ding, Y., Vaziri, N. D. (1998) Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 32: 718-723
4. Ding, Y., Vaziri, N. D. (2000) Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression. J. Pharmacol. Exp. Ther. 292: 606-609
5. 2+-current in single heart cells. Nature 323: 273-275
6. Kirstein, M., Rivet-Bastide, M., Hatem, S. (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J. Clin. Invest, 95: 794-802
7. Kishi, Y., Watanabe, T., Makita, T., Sakita, S., Watanabe, R., Ashikaga, T., Numano, F. (1995) Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells. J. Cardiovasc. Pharmacol. 26: 590-595
8. Lohmann, S. M., Fischmeister, R., Walter, U. (1991) Signal transduction by cGMP in heart. Basic Res. Cardiol. 86: 503-514
9. 2-muscarinic receptors in the human right atrium. Br. J. Pharmacol. 101: 363-369
10. Seya, K., Furukawa, K.-I., Motomura, S. (1999) A fluorometric assay for cyclic guanosine 3′,5′-monophosphate incorporating a Sep-Pak cartridge and enzymatic cycling. Anal. Biochem. 212: 243-249
11. 2+ in intact cardiac myocytes. Circ. Res. 14: 970-978
12. 2+ channel. J. Cardiovasc. Pharmacol. 6: S949-S955
13. 2+ channels. Trends Pharmacol. Sci. 12: 349-354
14. Wegener, J. W., Nawrath, H., Wolfsgruber, W., Kuhbandner, S., Werner, C., Hofmann, F., Feil, R. (2002) cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ. Res. 90: 18-20
15. Wu, C. C., Ko, F. N., Kuo, S. C., Lee, F. Y., Teng, C. M. (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116: 1973-1978
16. Zhuo, M., Hu, Y., Schulta, C., Kandel, E. R., Hawkins, R. D. (1994) Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368: 635-639